Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: J Neurosci Res. 2020 May 19;98(8):1532–1548. doi: 10.1002/jnr.24637

Table 5.

Tail-flick test.

Groups WT (1st, n=14; 2nd, n=5) MOR KO (1st, n=14; 2nd, n=6) Age X Genotype Weight X Genotype p for Age p for Weight p for Genotype
Estimate SE 95% CI Estimate SE 95% CI Z
1st cohort 0 0 0 −0.30 0.13 −0.55 and −0.05 −2.33 0.72 0.27 0.09 0.03* 0.02*
2nd cohort Midnight 0 0 0 −0.30 0.18 −0.65 and 0.05 −1.70 0.11 0.06 0.53 0.79 0.09
2nd cohort Midday 0 0 0 −0.42 0.11 −0.63 and −0.21 −3.95 0.19 0.23 0.75 0.25 <0.01*
2nd cohort Ropinirole 0 0 0 0.17 0.10 −0.02 and 0.36 1.78 0.98 0.22 0.22 0.40 0.08

The p-values for interactions were calculated by GENMOD with a gamma distribution with age, weight, and genotype as factors. The parameters and p-values for age, weight and genotype were calculated by GENMOD with a gamma distribution with the interaction removed.

*

p≤0.05;

**

p<0.01. WT, wild-type mice. MOR KO, mu opioid receptor knockout mice. SE, standard error. 95% CI, 95% confidence interval.